Severe T-mediated bone marrow aplasia in a patient with splenic lymphoma with villous lymphocytes (SLVL) previously treated with fludarabine regimen.
Rocco
Stefano
S
Division of Hematology, Ospedale S. Gennaro, Via S. Gennaro dei Poveri 25, 80134 Napoli, Italy. stefrocco@virgilio.it
Improta
Salvatore
S
Sagristani
Marco
M
Quirino
Ada A
AA
Nitrato Izzo
Giampiero
G
Russolillo
Silvia
S
Polistina
Maria Teresa
MT
Mastrullo
Lucia
L
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001855:Bone Marrow Diseases / Q000139:chemically induced*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D013160:Splenic Neoplasms / Q000188:drug therapy*; D013601:T-Lymphocytes / Q000187:drug effects / Q000473:pathology*; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine